The helix-loop-helix transcription factor HAND2 plays a vital role in the development of the heart, limb, facies, and other neural crest-derived structures. We used differential display analysis to identify 33 putative HAND2-regulated ESTs that are differentially expressed in Hand2 ؊/؊ vs wild-type mice. We determined the positions on mouse and human genetic maps of 29 of these by using the T31 mouse Radiation Hybrid panel, comparison to human genomic sequence, and comparative mapping. We examined the conserved chromosomal locations for phenotypes that involve development of heart, face, and limb structures that are affected by HAND2. One EST mapped to a region of conserved synteny between mouse chromosome 2 and human chromosome 10p. RACE analysis extended the sequence and identified this cDNA as the mouse ortholog of human nebulette, an actin-binding protein expressed in fetal heart. Nebulette was shown to be deleted in DiGeorge Syndrome 2 patients with the proximal deletion of human 10p13-p14 that is associated with cardiac and craniofacial abnormalities.
INTRODUCTION
Hand2, the gene encoding the basic helix-loop-helix transcription factor, HAND2, is expressed throughout prenatal development in the deciduum, heart, autonomic nervous system, and other neural crest-derived structures [1] . HAND2 is one of the earliest cardiac chamber-specific transcription factors identified to date [2] . By 9.5 days postcoitum (dpc) in the mouse embryo, HAND2 is expressed in the ventricular region, with abundant transcripts also in the outflow tract (conotruncus) and the first and second aortic arch arteries [1] . At 10.5 dpc, HAND2 is highly expressed in the first branchial arch (which gives rise to the craniofacial mesenchyme), the aortic sac, the third and fourth aortic arch arteries, and the truncus arteriosus [1] . HAND2 is also expressed in the limb bud where it plays a role in anteriorposterior polarization [3] . The same studies showed that ectopic expression of HAND2 results in the shortening and broadening of the long bones of the forearms and digits and preaxial polydactyly.
Mice homozygous for a null allele of Hand2 die from heart failure by 11 dpc [2] . Heart defects in the null embryos include lack of aortic arch arteries, a dilated aortic sac, and an abrupt connection between the outflow tract and the left ventricle, due to the absence of the right ventricle [2] . In these embryos, the first and second branchial arches become hypoplastic, most likely the result of extensive apoptosis, and the third and fourth branchial arches fail to form [4] . The lack of a critical amount of neural crest cells in the third and fourth branchial arches is thought to result in persistent truncus arteriosus (failure of septation of ascending aorta and pulmonary trunk) and interruption of the aorta, which are characteristic of DiGeorge syndrome (DGS)/velocardiofacial syndrome, also known as the 22q11 deletion syndrome [5] . In addition, Hand2 Ϫ/Ϫ mice demonstrated abnormal vascular development in the embryo and the yolk sac [6] .
Recent investigations of the molecular basis for DGS have shown that deletions of both copies of the Tbx1 or the Crkol gene in mouse disrupts development of the heart, thyroid, parathyroids, and craniofacial structure in patterns reminiscent of DGS [7] [8] [9] [10] . Segmental monosomy for a 1.5-Mb re-gion of mouse Chr 16 corresponding to most of the DGS region of Chr 22 produces these effects in a genetic model of the haploinsufficiency of DGS. Cardiac anomalies are largely reversed when a second copy of Tbx1 is added back to the segmentally monosomic mouse [9] , demonstrating a key role for this gene in this component of the DGS phenotype. However, the full complement of genetic interactions that are perturbed to produce the multiple phenotypes that characterize DGS remains to be elucidated.
In a previous study, characterization of ESTs differentially expressed in mice with or without a functional Hand2 gene demonstrated alteration of the expression of Ufd1l [11] . The Saccharomyces cerevisiae homolog, ufd1, is involved in degradation of ubiquitinated proteins. Ablation of yeast ufd1 disrupts cell survival and this perturbation is only partially reversed when a single copy of the gene is restored [12] . Human UFD1L maps to a region frequently deleted in DGS and thus was considered a candidate for associated anomalies based on dosage sensitivity, regulation by HAND2, pattern and timing of expression, and chromosomal position [11] . In this study, we determined the map positions in mouse and human of 29 additional genes whose expression may be altered in hearts of Hand2 Ϫ/Ϫ mice (A. Aiyer and D. Srivastava, in preparation) and compared these positions to mapped phenotypes including arrhythmogenic right ventricular dysplasia, dilated cardiomyopathy, cardiofaciocutaneous syndrome, and DGS. One of these is demonstrated to be the mouse ortholog of nebulette (NEBL), an actin-binding protein expressed primarily in the heart. NEBL transcripts have been isolated from human embryonic heart and early mouse fetuses. The gene localizes to the DiGeorge syndrome 2 (DGS2) region on human chromosome 10p14 -p13. Here we refine that localization with respect to the portion of the DGS2 deletion region that is correlated with cardiac defects, as opposed to the region of segmental monosomy in individuals with the hypoparathyroidism, deafness, and renal dysplasia (HDR) spectrum of anomalies.
RESULTS

Mapping of ESTs
Twenty-nine ESTs isolated through differential display analysis (DDA sequences) or subtractive hybridization (RDA sequences) were unique. We developed primers from these, and 22 of them were mapped with high confidence (lod scores ranging from 6.1 to 25.6) on the T31 mouse Radiation Hybrid (RH) panel (Table 1 and http://www.jax.org/ resources/documents/cmdata/rhmap/RHIntro.html). One transcript, DDA34, represents the mouse gene, Enolase2 (Eno2), which was mapped previously to chromosome 6, map position 60.21, by backcross and physical mapping. We mapped Eno2 on the RH panel to mouse chromosome 6 between 57 and 60 map units to validate the RH mapping procedures. DDA38, which represents mouse Kcnq1, was mapped previously to chromosome 7, map position 69.3, by backcross and physical mapping. The human ortholog, KCNQ1, has been located on human chromosome 11p15.5. We mapped Kcnq1 to distal mouse chromosome 7, between 71 and 72 map units. Nine additional ESTs corresponded to genes mapped previously in mouse or human (Table 2) . Twenty-one of the 22 mapped ESTs were localized to mouse chromosomal regions with an interval size Ͻ4 map units (Table 1) .
We initially used comparison of mouse and human genetic maps to predict the most likely locations in both mouse and human genomes of orthologous genes (Table 1 ) (see Materials and Methods). Of the 22 ESTs mapped by the RH panel, 18 had an unambiguous predicted human location and 4 mouse positions did not discriminate between two possible locations in the human genome (Table 1 ). To resolve some of these ambiguities, we compared the DDA sequences by BLAST to human and mouse genomic sequence. No matches were found to publicly available mouse genomic sequence. However, 15 of them detected one or more significant human matches, and 14 of these matched the predicted chromosomal location with the highest homology score, refining and confirming predictions from comparative mapping. The 7 sequences that could not be mapped on the RH panel had strong hits in human sequence, such that comparative mapping predicted the mouse genomic location. One sequence, RDA30, mapped to a position on mouse Chr 4 that predicted a human ortholog on human chromosome 9p21-p22, but this sequence detected human genomic sequence matches on chromosomes 6 and 11 (Table 1) . Mouse Chr 4 contains a small segment of chromosome 6 homology located between conserved syntenies with human chromosomes 8 and 9. RDA30 may represent a gene from a segment that is separated from the few other human chromosome 6 genes on this mouse chromosome, or the gene order may be incorrect on the composite mouse map. Mouse genome sequencing will resolve this issue.
DDA Sequence Expression and Mapped Phenotypes
Twenty-two unique sequences from the differential display analysis could be shown independently to be transcribed sequences based on expression studies or EST matches (Table 2). Twelve of these matched known mouse genes and/or their human orthologs. We identified and mapped a number of these for the first time in mouse or human. Nine DDA sequences matched sequences in "full-length-enriched" Riken cDNA libraries [13] . Six were confirmed to occur in heart and/or early embryo.
We identified phenotypes in humans and mice that map near to each EST position in OMIM and MGD ( Table 1 ). Anomalies that involve the heart, vascular system, limb, facies, and neural crest-derived structures might be consistent with the known effects of HAND2. In addition, effects on melanocytes, calcitonin-secreting cells, and the adrenal gland could arise as a result of the loss of HAND2 expression affecting neural crest development and migration [11] . Several DDA sequences mapped to the same chromosomal regions as phenotypes affecting the heart, such as arrhythmogenic right ventricular dysplasia (DDA23, 26, 30, 47), other cardiomyopathies (DDA9, 35, 47), and QT syndrome (DDA38). Two ESTs mapped in human chromosomal regions associated with syndromes that involve both congenital heart defects and craniofacial defects. The human ortholog of DDA29 mapped to HSA 12q24.11, the same region as cardiofaciocutaneous syndrome, while DDA23 mapped to the region responsible for DGS2 on HSA10. We characterized DDA23 further.
DDA23 Is the Mouse Ortholog of Nebulette (NEBL)
Comparative mapping predicted that the human ortholog of DDA23 would be located on 10p14 -p13. Haploinsufficiency for this region of HSA 10 results in a clinical presentation of DiGeorge syndrome [14, 15] . The short DDA23 sequence (448 bp) did not match known genes or ESTs. However, extension of the sequence using 5Ј and 3Ј rapid amplification of cDNA ends (RACE) identified significant homology to human NEBL ( Table 2 ). The open reading frame of human fetal nebulette encodes a 115-kDa cardiac actin-binding protein that shares homology with human skeletal muscle nebulin [16, 17] . The current study identifies nebulette (as DDA23) from E9.5 mouse heart. nebulette has been identified previously in cDNA libraries of human fetal heart (HSY17673) and embryonic day 13 mouse heart (BB658903). To confirm expression in fetal heart, we performed RT-PCR on mRNA from E9.5 mouse hearts. A nebulette product was obtained from both wild-type and Hand2 Ϫ/Ϫ hearts. Amplification using equal starting amounts of RNA showed a consistent reduction of about fourfold in nebulette product from Hand2 Ϫ/Ϫ hearts after 18, 20, 22, or 24 cycles of PCR.
Mapping of Human nebulette Using Fluorescence in Situ Hybridization (FISH)
Previous gene mapping studies indicated that human nebulette is mapped to chromosome 10p12 [18] . To identify more precisely the location of NEBL in relation to the DGS2 region, we examined cell lines with 10p deletions by FISH using overlapping BACs that contain the gene (Fig. 1) . The BACs were absent from two of the deleted cell lines, CH95-199 and GM03470. CH95-199 was derived from a female with a cardiac defect, immune deficiency, cleft palate, facial dysmorphia, and developmental delay [19] . GM03470 was derived from a female with microcephaly, microphthalmia, and hypotelorism. The BACs were not deleted from the GM06936 or CH92-092 cell lines, which were derived from patients who had hypocalcemia, immune defect, developmental delay, and renal or genitourinary anomalies (hypoplasia and ureteral reflux, respectively). Neither of these individuals had a cardiac defect. Thus, their features were consistent with the HDR spectrum of DGS2 anomalies. The BAC was present on the der(10) in GM10207, which narrows the gene location to the interval shown in Fig. 1 .
DISCUSSION
HAND2 plays an important role during development, and genes expressed downstream of it may be candidates for anomalies of the heart, vascular system, facies, limb, and various neural crest-derived structures. In this study, genes whose expression was affected in hearts of Hand2 Ϫ/Ϫ mice, as determined by differential display, were mapped to several chromosomal regions linked to phenotypes judged to be consistent with the known effects of HAND2. One gene in particular, human nebulette, is expressed in early heart development and maps to the candidate region for heart defects in DiGeorge Syndrome 2 on HSA 10p.
Several of the putative HAND2-dependent genes identified here have vital functions in development. The targeted disruption of Kif5b (DDA5) results in embryonic lethality in the mouse, with severe growth retardation at 9.5-11.5 dpc [20] . Kif5b is essential for mitochondrial and lysosomal dispersion [20] . Usp2 (DDA8) is a ubiquitin-specific protease, inhibition of which may result in apoptosis in cells of the developing heart [11] .
Several genes that show significant sequence similarity to the ESTs obtained by differential display have abundant transcripts in the heart. Kcnq1, represented by DDA38, is expressed during mouse development, beginning at embryonic day 9.5, within the atrial and ventricular myocardium [21] . Aclp7, which shares significant sequence similarity with DDA7, is an actin-binding protein that is expressed mainly in the lung, brain, spinal cord, and skeletal and cardiac muscle [22] . This gene mapped to the same human chromosomal region as Schwartz-Jampel syndrome (Table 1) , which includes facial abnormalities consistent with the Hand2 Ϫ/Ϫ expression pattern. Many phenotypes mapped to the same regions, as HAND2-dependent ESTs were characterized by anomalies in structures other than heart that have been shown to express HAND2 during development, e.g., the limb and facies (Table 1) . Finally, HAND2 may play a role in neural crest differentiation and migration. The mouse mutant phenotypes recessive spotting, rump white, and patch deletion region, which involve neural crest-derived melanocytes, map on MMU5 near DDA28.
Four ESTs mapped near regions linked to dilated cardiomyopathy (Table 1) . Two of these loci (represented by DDA30 and 47) are also linked to arrythmogenic right ventricular dysplasia (ARVD). DDA47 matches a RIKEN fulllength clone ( Table 2 ) that is closely related to myotubularin (Mtm1) and myotubularin-related (Mtmr1) genes (GenBank Accession No. AF125314, e-103). Mutations in myotubularin have been linked to dilated cardiomyopathy [23] [24] [25] . KCNQ1, the human ortholog of DDA38, mapped to a chromosomal region linked to syndromes characterized by cardiac arrhythmias, Long QT syndrome (LQTS) and Jervell and Lange-Nielsen syndrome (JLNS). It has been proposed that mutations in KCNQ1 provide a molecular basis for the cardiac arrhythmias seen in LQTS and JLNS [26 -28] .
Two ESTs mapped to loci responsible for congenital diseases that demonstrate anomalies of the heart and craniofacial structures. The human ortholog of DDA29, ATP2A2, localizes to a chromosomal region characterized by cardiofaciocutaneous syndrome. Patients with this syndrome commonly exhibit pulmonic stenosis, atrial septal defect, and characteristic facial appearance (http://www.ncbi.nlm.nih. gov/entrez/query.fcgi?db ϭ OMIM). The ATP2A2 gene encodes the sarco(endo)plasmic reticulum Ca 2ϩ -ATPase2 (SERCA2) isoforms [29] . The ATP2A2a isoform (SERCA2a) is expressed mainly in the cardiac and skeletal muscle, and its expression and sarcoplasmic Ca 2ϩ handling are decreased 
